Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP550192.RAOoeCu0iLE5MN7-jfzZi1XdIrTZ_uD9BFLTG-J_qC-SA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP550192.RAOoeCu0iLE5MN7-jfzZi1XdIrTZ_uD9BFLTG-J_qC-SA130_assertion type Assertion NP550192.RAOoeCu0iLE5MN7-jfzZi1XdIrTZ_uD9BFLTG-J_qC-SA130_head.
- NP550192.RAOoeCu0iLE5MN7-jfzZi1XdIrTZ_uD9BFLTG-J_qC-SA130_assertion description "[MDM2 G/G was associated with markedly reduced survival in squamous cell carcinoma (MS of 10.3 versus 49.4 months; adjusted hazard ratio for death, 7.9; 95% confidence interval, 2.4-26.0; P = 0.0007 for G/G versus T/T) but not in adenocarcinoma (SNP-histology interaction P = 0.004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP550192.RAOoeCu0iLE5MN7-jfzZi1XdIrTZ_uD9BFLTG-J_qC-SA130_provenance.
- NP550192.RAOoeCu0iLE5MN7-jfzZi1XdIrTZ_uD9BFLTG-J_qC-SA130_assertion evidence source_evidence_literature NP550192.RAOoeCu0iLE5MN7-jfzZi1XdIrTZ_uD9BFLTG-J_qC-SA130_provenance.
- NP550192.RAOoeCu0iLE5MN7-jfzZi1XdIrTZ_uD9BFLTG-J_qC-SA130_assertion SIO_000772 19383811 NP550192.RAOoeCu0iLE5MN7-jfzZi1XdIrTZ_uD9BFLTG-J_qC-SA130_provenance.
- NP550192.RAOoeCu0iLE5MN7-jfzZi1XdIrTZ_uD9BFLTG-J_qC-SA130_assertion wasDerivedFrom befree-20150227 NP550192.RAOoeCu0iLE5MN7-jfzZi1XdIrTZ_uD9BFLTG-J_qC-SA130_provenance.
- NP550192.RAOoeCu0iLE5MN7-jfzZi1XdIrTZ_uD9BFLTG-J_qC-SA130_assertion wasGeneratedBy ECO_0000203 NP550192.RAOoeCu0iLE5MN7-jfzZi1XdIrTZ_uD9BFLTG-J_qC-SA130_provenance.